Published in Hepatitis Weekly, August 1st, 2005
"The presence of antibodies to the 210-kDa glycoprotein of the nuclear pore complex (gp210) is highly indicative of primary biliary cirrhosis (PBC). However, the significance of anti-gp210 antibody titers for monitoring PBC remains unresolved," scientists writing in the Journal of Hepatology report.
"We used an enzyme-linked immunosorbent assay (ELISA) with a gp210 C-terminal peptide as an antigen to assess serum antibody titers in 71 patients with PBC. Patients were classified into three groups: group A in whom anti-gp210 titers were sustained at a high level, group...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly